英文名稱 |
中文名稱 |
CAS號 |
操作 |
Pexidartinib hydrochloride |
培西達(dá)替尼鹽酸鹽 |
2040295-03-0 |
詳細(xì)
|
CCT241736 |
CS-2683 |
1402709-93-6 |
詳細(xì)
|
SYN1143 |
N-[3-氟-4-[(7-甲氧基喹啉-4-基)氧基]苯基]-1-(2-羥基-2-甲基丙基)-5-甲基-3-氧代-2-苯基-2,3-二氫-1H-吡唑-4-甲酰胺 |
913376-84-8 |
詳細(xì)
|
PP58 |
Pyrido[2,3-d]pyrimidin-7(8H)-one,2-[[4-(2-aminoethoxy)phenyl]amino]-6-(2,6-dichlorophenyl)-8-methyl- |
212391-58-7 |
詳細(xì)
|
VEGFR-2-IN-5 |
N2-[4-[(3-氨基丙基)氨基]苯基]-N4-(5-環(huán)丙基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
1430089-64-7 |
詳細(xì)
|
SCR-1481B1 |
麥他替尼胺丁三醇 |
1174161-86-4 |
詳細(xì)
|
Indirubin Derivative E804 |
Indirubin Derivative E804 |
854171-35-0 |
詳細(xì)
|
c-Fms-IN-1 |
C-FMS-IN-1 |
885703-64-0 |
詳細(xì)
|
BBT594 |
BBT594 |
882405-89-2 |
詳細(xì)
|
CCG215022 |
CCG215022 |
1813527-81-9 |
詳細(xì)
|
NAMI-A |
201653-76-1 |
201653-76-1 |
詳細(xì)
|
NVP-ACC789 |
N-(3-溴-4-甲基苯基)-4-(4-吡啶甲基)-1-酞嗪胺 |
300842-64-2 |
詳細(xì)
|
Glesatinib hydrochloride |
CS-2642 |
1123838-51-6 |
詳細(xì)
|
ASP5878 |
ASP-5878 |
1453208-66-6 |
詳細(xì)
|
Linifanib |
利尼伐尼 |
796967-16-3 |
詳細(xì)
|
Crizotinib hydrochloride |
克里唑替尼鹽酸 |
1415560-69-8 |
詳細(xì)
|
Ibrutinib deacryloylpiperidine |
伊布替尼中間體N-2 |
330786-24-8 |
詳細(xì)
|
BMX-IN-1 |
N-[2-甲基-5-[9-[4-[(甲基磺?;?氨基]苯基]-2-氧代苯并[H]-1,6-萘啶-1(2H)-基]苯基]-2-丙烯酰胺 |
1431525-23-3 |
詳細(xì)
|
QL47 |
1469988-75-7 |
1469988-75-7 |
詳細(xì)
|
Trapidil |
樂可安 |
15421-84-8 |
詳細(xì)
|
Metadoxine |
美他多辛 |
74536-44-0 |
詳細(xì)
|
Tanshinone IIA |
丹參酮 IIA |
568-72-9 |
詳細(xì)
|
Formononetin |
刺芒柄花素 |
485-72-3 |
詳細(xì)
|
Scutellarein |
野黃芩素 |
529-53-3 |
詳細(xì)
|
Fangchinoline |
防己諾林堿 |
436-77-1 |
詳細(xì)
|
Bilobetin |
7-去甲基銀杏雙黃酮 |
521-32-4 |
詳細(xì)
|
7-Hydroxy-4-chromone |
7-羥基色原酮 |
59887-89-7 |
詳細(xì)
|
Insulin (human) |
重組人胰島素 |
11061-68-0 |
詳細(xì)
|
PKI(5-24) |
THR-THR-TYR-ALA-ASP-PHE-ILE-ALA-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP |
99534-03-9 |
詳細(xì)
|
Kemptide |
肯普肽 |
65189-71-1 |
詳細(xì)
|
Insulin(cattle) |
牛胰島素 |
11070-73-8 |
詳細(xì)
|
PKI 14-22 amide,myristoylated |
PKI 14-22 AMIDE, MYRISTOYLATED |
201422-03-9 |
詳細(xì)
|
CREBtide |
多肽CREBtide |
149155-45-3 |
詳細(xì)
|
GIP (3-42), human |
GIP (3 - 42), human |
1802086-25-4 |
詳細(xì)
|
MK-4101 |
5-(3,3-二氟環(huán)丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]雙環(huán)[2.2.2]辛烷-1-基]-1,2,4-惡二唑 |
935273-79-3 |
詳細(xì)
|
Bevacizumab |
貝伐珠單抗 |
216974-75-3 |
詳細(xì)
|
Ramucirumab |
雷莫蘆單抗 |
947687-13-0 |
詳細(xì)
|
Pz-1 |
1800505-64-9 |
1800505-64-9 |
詳細(xì)
|
DDR1-IN-2 |
DDR1-IN-2 |
1429617-90-2 |
詳細(xì)
|
c-Fms-IN-2 |
791587-67-2 |
791587-67-2 |
詳細(xì)
|
DDR Inhibitor |
1644069-80-6 |
1644069-80-6 |
詳細(xì)
|
CGP77675 |
CGP 77675; CGP-77675 |
234772-64-6 |
詳細(xì)
|
TAK-593 |
1005780-62-0 |
1005780-62-0 |
詳細(xì)
|
Tyrphostin A9 |
酪氨酸磷酸化抑制劑A9 |
10537-47-0 |
詳細(xì)
|
Merestinib dihydrochloride |
N-[3-氟-4-[[1-甲基-6-(1H-吡唑-4-基)-1H-吲唑-5-基]氧基]苯基]-1-(4-氟苯基)-1,2-二氫-6-甲基-2-氧代-3-吡啶甲酰胺二鹽酸鹽 |
1206801-37-7 |
詳細(xì)
|
Ceritinib dihydrochloride |
雙鹽酸鹽色瑞替尼 |
1380575-43-8 |
詳細(xì)
|
GZD824 |
GZD824 |
1257628-77-5 |
詳細(xì)
|
GZD824 dimesylate |
GZD824DIMESYLATE |
1421783-64-3 |
詳細(xì)
|
c-Met inhibitor 1 |
3-[(2-甲基-2H-吲唑-5-基)硫基]-6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-B]噠嗪 |
1357072-61-7 |
詳細(xì)
|
A 419259 trihydrochloride |
7-[反式-4-(4-甲基-1-哌嗪基)環(huán)己基]-5-(4-苯氧基苯基)-7H-吡咯并[2,3-D]嘧啶-4-胺三鹽酸鹽 |
1435934-25-0 |
詳細(xì)
|
Tirabrutinib |
替拉魯替尼 |
1351636-18-4 |
詳細(xì)
|
CEP-37440 |
CEP-37440 |
1391712-60-9 |
詳細(xì)
|
AMG 925 |
AMG-925 |
1401033-86-0 |
詳細(xì)
|
H-89 |
N-[2-[P-溴苯丙烯鹽基氨基]乙基]-5-異喹啉磺酰胺 |
127243-85-0 |
詳細(xì)
|
BIBF 1202 |
BIBF 1202 |
894783-71-2 |
詳細(xì)
|
Ilorasertib hydrochloride |
ILORASERTIB HYDROCHLORIDE (ABT-348 HYDROCHLORIDE) |
1847485-91-9 |
詳細(xì)
|
EOC317 |
ACTB-1003 |
939805-30-8 |
詳細(xì)
|
JI-101 |
JI-101 |
900573-88-8 |
詳細(xì)
|
SANT-1 |
SANT1 |
304909-07-7 |
詳細(xì)
|
Rho-Kinase-IN-1 |
Rho-Kinase-IN-1 |
1035094-83-7 |
詳細(xì)
|
SRI-011381 hydrochloride |
SRI-011381 (hydrochloride) |
2070014-88-7 |
詳細(xì)
|
GNF-6231 |
GNF6231 |
1243245-18-2 |
詳細(xì)
|
XMU-MP-1 |
XMU-MP-1 |
2061980-01-4 |
詳細(xì)
|
Y-33075 |
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺 |
199433-58-4 |
詳細(xì)
|
Y-33075 dihydrochloride |
Y39983 HYDROCHLORIDE |
173897-44-4 |
詳細(xì)
|
Y-27632 |
Y-27632二鹽酸鹽 |
146986-50-7 |
詳細(xì)
|
Toxoflavin |
毒黃素 |
84-82-2 |
詳細(xì)
|
Ciliobrevin A |
HPI-4 |
302803-72-1 |
詳細(xì)
|
IWP-O1 |
IWP-O1 |
2074607-48-8 |
詳細(xì)
|
SKL2001 |
SKL2001 |
909089-13-0 |
詳細(xì)
|
KYA1797K |
CS-2581 |
1956356-56-1 |
詳細(xì)
|
KY1220 |
292168-79-7 |
292168-79-7 |
詳細(xì)
|
iCRT3 |
CS-2716 |
901751-47-1 |
詳細(xì)
|
Vismodegib |
維莫德吉 |
879085-55-9 |
詳細(xì)
|
Neurodazine |
2-[5-(3-Chlorophenyl)-2-furanyl]-4,5-bis(4-methoxyphenyl)-1H-imidazole |
937807-66-4 |
詳細(xì)
|
SB-772077B dihydrochloride |
SB 772077B DIHYDROCHLORIDE |
607373-46-6 |
詳細(xì)
|
WAY 316606 |
5-(苯磺?;?-N-(哌啶-4-基)-2-(三氟甲基)苯磺酰胺 |
915759-45-4 |
詳細(xì)
|
Adavivint |
SM04690 |
1467093-03-3 |
詳細(xì)
|
Tegatrabetan |
1227637-23-1 |
1227637-23-1 |
詳細(xì)
|
PNU-74654 |
PNU 74654,2-PHENOXYBENZOICACID-[(5-METHYL-2-FURANYL)METHYLENE]HYDRAZIDE |
113906-27-7 |
詳細(xì)
|
ZINC00881524 |
557782-81-7 |
557782-81-7 |
詳細(xì)
|
EMT inhibitor-1 |
FWMUIOJZHOPPDX-UHFFFAOYSA-N |
1638526-21-2 |
詳細(xì)
|
LF3 |
LF3 |
664969-54-4 |
詳細(xì)
|
TBCA |
Casein Kinase II Inhibitor III |
934358-00-6 |
詳細(xì)
|
WAY-262611 |
MAY-262611 |
1123231-07-1 |
詳細(xì)
|
Casein Kinase II Inhibitor IV |
863598-09-8 |
863598-09-8 |
詳細(xì)
|
YAP/TAZ inhibitor-1 |
2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime |
2093565-23-0 |
詳細(xì)
|
Porcn-IN-1 |
Porcupine-IN-1 |
2036044-77-4 |
詳細(xì)
|
NRX-252262 |
化合物NRX-252262 |
2438637-61-5 |
詳細(xì)
|
DK419 |
DK419 |
2102672-22-8 |
詳細(xì)
|
CUR61414 |
CUR 61414 |
334998-36-6 |
詳細(xì)
|
FzM1.8 |
Fzd4 agonist FzM1.8) |
2204290-85-5 |
詳細(xì)
|
ALLO-2 |
ALLO-2
(Smo inhibitor ALLO-2) |
1357350-60-7 |
詳細(xì)
|
MRT00033659 |
MRT00033659 |
1401731-54-1 |
詳細(xì)
|
ROCK inhibitor-2 |
ROCK inhibitor-2 |
1127308-52-4 |
詳細(xì)
|
SSTC3 |
SSTC3 |
1242422-09-8 |
詳細(xì)
|
MSAB |
MSAB |
173436-66-3 |
詳細(xì)
|
Dynarrestin |
Dynarrestin |
2222768-84-3 |
詳細(xì)
|
IWR-1 |
IWR-1 |
1127442-82-3 |
詳細(xì)
|
Glabrescione B |
GLABRESCIONE B |
65893-94-9 |
詳細(xì)
|